# Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients

> **NCT01876186** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Overactive Bladder Syndrome

## Interventions

- **DRUG:** Solifenacin for 12 weeks
- **DRUG:** Solifenacin for 24 weeks

## Key facts

- **NCT ID:** NCT01876186
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2015-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01876186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01876186, "Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01876186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*